Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;22:569-576

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gray, G. A.
Right arrow Articles by Baumgartner, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gray, G. A.
Right arrow Articles by Baumgartner, H. R.

Hypertension, Vol 22, 569-576, Copyright © 1993 by American Heart Association


ARTICLES

Effects of calcium channel blockade on the aortic intima in spontaneously hypertensive rats

GA Gray, M Clozel, JP Clozel and HR Baumgartner
Preclinical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland.

Hypertension is associated with an intimal dysfunction characterized by endothelium-dependent constriction to serotonin, decreased endothelium- dependent relaxation to acetylcholine, and a subendothelial infiltration of monocyte-macrophages. The goal of our study was to evaluate the effect of long-term calcium channel blockade with Ro 40- 5967, a new long-acting calcium channel blocker, on these alterations in aortas of spontaneously hypertensive rats (SHR). Arterial blood pressure was decreased by Ro 40-5967. In aortas from Ro 40-5967-treated SHR, the serotonin ratio (maximal contraction to serotonin on rings with endothelium over maximal contraction on paired rings without endothelium) was reduced (1.14 +/- 0.10) compared with control SHR (1.72 +/- 0.12, P < .01) because of inhibition of maximal contraction in rings with endothelium. This effect of Ro 40-5967 was partially reversed by an inhibitor of nitric oxide (NO) synthase, NG-nitro-L- arginine-methyl ester, and partially inhibited in the presence of the thromboxane/prostaglandin H2 receptor antagonist AH 23848. Maximal relaxation to acetylcholine in rings with endothelium was increased by Ro 40-5967. In rings without endothelium, Ro 40-5967 treatment enhanced the sensitivity to sodium nitroprusside-induced relaxation. Cyclic GMP content, an indicator of NO release, was not increased in aortas from Ro 40-5967-treated SHR. Thus, improvement of endothelial function was probably achieved by facilitating the action of NO at the level of the smooth muscle cells and by reducing prostaglandin H2-induced constriction. Finally, the number of monocyte-macrophages in the subendothelium was decreased by Ro 40-5967. 40-5967.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Feletou and P. M. Vanhoutte
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Am J Physiol Heart Circ Physiol, September 1, 2006; 291(3): H985 - H1002.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Kagota, A. Tamashiro, Y. Yamaguchi, K. Nakamura, and M. Kunitomo
High Salt Intake Impairs Vascular Nitric Oxide/Cyclic Guanosine Monophosphate System in Spontaneously Hypertensive Rats
J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 344 - 351.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Ding and N. D. Vaziri
Nifedipine and Diltiazem but Not Verapamil Up-Regulate Endothelial Nitric-Oxide Synthase Expression
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 606 - 609.
[Abstract] [Full Text]


Home page
HypertensionHome page
Y. Ding and N. D. Vaziri
Calcium Channel Blockade Enhances Nitric Oxide Synthase Expression by Cultured Endothelial Cells
Hypertension, October 1, 1998; 32(4): 718 - 723.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T.-C. Chou, M.-H. Yen, C.-Y. Li, and Y.-A. Ding
Alterations of Nitric Oxide Synthase Expression With Aging and Hypertension in Rats
Hypertension, February 1, 1998; 31(2): 643 - 648.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
H. Shirahase, Y. Uehara, M. Kanda, K. Wada, A. Ichikawa, Y. Kobayashi, and N. Funahashi
Protective Effects of Iganidipine on Morphological and Functional Changes of Arteries in Hypertensive Dahl Rats
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(2): 143 - 152.
[Abstract] [PDF]


Home page
HypertensionHome page
C. F. Kung, P. Moreau, H. Takase, and T. F. Luscher
L-NAME Hypertension Alters Endothelial and Smooth Muscle Function in Rat Aorta : Prevention by Trandolapril and Verapamil
Hypertension, November 1, 1995; 26(5): 744 - 751.
[Abstract] [Full Text]